Filing Overview
Registrant: Soaring Eagle Acquisition Corp., the SPAC associated with the proposed Ginkgo Bioworks transaction. The filing date and earliest reported event date were April 15, 2021. The filing is an 8-K under Item 8.01, Other Events.
Business Context and Reporting Period
This filing does not present operating results for Ginkgo Bioworks Holdings, Inc. or Soaring Eagle Acquisition Corp. It announces the planned separation and separate trading of the securities comprising the company’s units, commencing on or about April 19, 2021.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, valuation, or other operating and financial metrics.
Material Changes and Securities Trading
- Each unit consists of one Class A ordinary share and one-fifth of one redeemable warrant.
- Holders may elect to separate units into Class A ordinary shares and warrants beginning on or about April 19, 2021.
- Units not separated continue to trade on Nasdaq under the symbol SRNGU.
- Separated Class A ordinary shares and warrants trade under SRNG and SRNGW, respectively.
- Each whole warrant is exercisable for one Class A ordinary share at an exercise price of $11.50 per share.
- No fractional warrants will be issued upon separation; only whole warrants will trade.
- Holders must have their brokers contact Continental Stock Transfer & Trust Company, the transfer agent, to separate units.
Guidance, Risks, and Unusual Items
The filing provides no financial guidance or operating outlook. The principal investor consideration is the mechanics of unit separation, including the inability to trade fractional warrants and the requirement for broker-directed processing. The filing does not disclose additional contingencies or unusual financial items.
Facts Investors Should Verify
- Whether the unit separation and separate trading commenced on or about April 19, 2021 as announced.
- The applicable broker procedures and timing for separating units.
- The number of whole warrants received after separation and the related $11.50 exercise price.
- That this filing is by Soaring Eagle Acquisition Corp. and contains no Ginkgo operating or financial results.
- The status and terms of the proposed business combination and related transaction disclosures in other filings.